Clorox Co (NYSE:CLX) Big Money Sentiment Index Improved in Q4 2018 to 0.88

The Clorox Company (NYSE:CLX) Corporate Logo

Clorox Co’s Sentiment

In Q4 2018 Clorox Co (NYSE:CLX) big money sentiment increased to 0.88, according to SEC.gov filings. That’s up 0.02, from 2018Q3’s 0.86. 270 active investment managers increased or started new positions, while 308 sold and decreased holdings in Clorox Co so the sentiment has improved. Funds own 101.14 million shares, up from 95.79 million shares in 2018Q3. Funds holding Clorox Co in top 10 changed to 11 from 7 for an increase of 4. In total 49 funds closed positions, 259 reduced and 187 increased. Also 83 funds bought new Clorox Co stakes.

Significant Clorox Co Shareholders

Cedar Rock Capital Ltd owns 2.88 million shares in Clorox Co as of Q4 2018. As of Q4 2018, 101,650 shares of Clorox Co are owned by America First Investment Advisors Llc. Also, Symons Capital Management Inc reported 63,765 shares in Clorox Co equivalent to 4.08% of its long stock exposure. The Oregon-based fund Peregrine Asset Advisers Inc. have invested about 3.51% of the investment professional’s stock portfolio in Clorox Co. The New York-based fund Reilly Herbert Faulkner Iii holds 37,999 shares or 3.18% of their long stock exposure.

The Clorox Company manufactures and markets consumer and professional products worldwide.The company has $19.80 billion market cap. It operates through four divisions: Cleaning, Household, Lifestyle, and International.25.53 is the P/E ratio. The firm offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighters and color boosters; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning and disinfecting products under the Clorox, Dispatch, Aplicare, HealthLink, and Clorox Healthcare brands.

CLX touched $154.45 during the last trading session after $1.04 change.The Clorox Company has volume of 735,955 shares. Since April 16, 2018 CLX has risen 21.73% and is uptrending. The stock outperformed the S&P500 by 17.36%.

The Clorox Company (NYSE:CLX)’s earnings release is expected by WallStreet on May, 1, Zacks reports. Analysts have expectation on stock’s EPS of $1.48. That’s up 8.03 % from last year’s $1.37 EPS. This could be $189.68 million profit for CLX assuming the current $1.48 EPS will become reality. Wall Street forecasts 5.71 % EPS growth as of May, 1.

Amp Ltd stated it has 0.05% in The Clorox Company (NYSE:CLX). Visionary Asset Mgmt invested 0.09% of its capital in The Clorox Company (NYSE:CLX). Winch Advisory Services Ltd Liability Corporation holds 5 shs. Morgan Stanley holds 0.09% or 1.93M shs in its capital. Thomasville Bankshares, a Georgia-based fund reported 3,375 shs. Moreover, Sonata Cap has 0.36% invested in The Clorox Company (NYSE:CLX) for 2,856 shs. The United Kingdom-based Barclays Public Limited Co has invested 0.03% in The Clorox Company (NYSE:CLX). The North Carolina-based Parsec Inc has invested 0.02% in The Clorox Company (NYSE:CLX). Mairs holds 1,513 shs or 0% of its capital. Texas Yale Cap Corporation reported 12,430 shs or 0.17% of all its holdings. Transamerica Financial Advisors Incorporated invested in 0.01% or 370 shs. Thompson Siegel Walmsley Limited Liability Corp reported 67 shs stake. Moreover, Mitchell Mcleod Pugh Williams has 0.81% invested in The Clorox Company (NYSE:CLX) for 6,574 shs. Putnam Invs Lc stated it has 44,801 shs or 0.02% of all its holdings. Shine Invest Advisory Ser Incorporated holds 0.01% of its capital in The Clorox Company (NYSE:CLX) for 89 shs.

The Clorox Company registered $52.54 million net activity with 0 insider buys and 10 sales since November 6, 2018. On Tuesday, December 4 Dorer Benno O sold $25.13M worth of The Clorox Company (NYSE:CLX). Baker Jeff sold $600,487 worth of stock. $4.27M worth of The Clorox Company (NYSE:CLX) shs were sold by Willoughby Dawn C. On Thursday, December 6 a trade for 18,366 shs valued at $3.00 million was made by GARNER DENISE. The insider Barral Diego J sold $2.03M. On Thursday, November 15 $1.10M worth of stock was sold by Costello Michael R..

The Clorox Company (NYSE:CLX) Ratings Coverage

Total analysts of 6 have positions in Clorox (NYSE:CLX) as follows: 2 rated it a “Buy”, 2 with “Sell” and 2 with “Hold”. The positive are 33%. Since October 17, 2018 according to StockzIntelligence Inc Clorox has 11 analyst reports. On Friday, November 2 the firm earned “Neutral” rating by Citigroup. The stock rating was maintained by Wells Fargo with “Market Perform” on Wednesday, October 17. On Friday, November 2 the stock of The Clorox Company (NYSE:CLX) earned “Outperform” rating by BMO Capital Markets. On Thursday, February 21 the rating was maintained by Wells Fargo with “Hold”. On Thursday, November 1 the stock has “Sell” rating by Deutsche Bank. On Wednesday, December 12 the firm has “Market Perform” rating by Wells Fargo given. In Tuesday, November 20 report Citigroup maintained the stock with “Neutral” rating. The stock rating was downgraded by JP Morgan to “Underweight” on Monday, April 8. On Wednesday, March 20 Deutsche Bank maintained the shares of CLX in report with “Sell” rating.

For more The Clorox Company (NYSE:CLX) news published briefly go to: Streetinsider.com, Seekingalpha.com, Benzinga.com, Seekingalpha.com or 247Wallst.com. The titles are as follows: “Pre-Open Stock Movers 04/08: (CHRS) (NBEV) (SNAP) Higher; (ROKU) (GE) (BA) Lower (more…) – StreetInsider.com” published on April 08, 2019, “How Safe Is Clorox’s Dividend? – Seeking Alpha” on February 28, 2019, “10 Biggest Price Target Changes For Monday – Benzinga” with a publish date: April 08, 2019, “More on Clorox’s Q2 bottom-line beat – Seeking Alpha” and the last “Top Analyst Upgrades and Downgrades: AEP, Boeing, Dollar Tree, GE, Micron, NextEra, P&G, Roku, Snap, Starbucks, Tesla, Wynn and More – 24/7 Wall St.” with publication date: April 08, 2019.

The Clorox Company (NYSE:CLX) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.